Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Ended earlyNCT05849246
What this trial is testing

The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 4
Testing effectiveness (Phase 2)WithdrawnNCT01179269
What this trial is testing

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Loyola University
Testing effectiveness (Phase 2)Ended earlyNCT00664105
What this trial is testing

Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 63
Testing effectiveness (Phase 2)UnknownNCT00663689
What this trial is testing

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Guangdong Provincial People's Hospital 45
Testing effectiveness (Phase 2)UnknownNCT06108726
What this trial is testing

Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Northern Jiangsu People's Hospital 16
Testing effectiveness (Phase 2)Study completedNCT01580735
What this trial is testing

ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Kyowa Kirin Co., Ltd. 40
Not applicableEnded earlyNCT01799135
What this trial is testing

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Dana-Farber Cancer Institute 6
Not applicableUnknownNCT03667885
What this trial is testing

Non-Invasive Diagnostics of Small Renal Masses

Who this might be right for
Renal Cell CarcinomaRenal Tumor
Odense University Hospital 160
Not applicableStudy completedNCT03615443
What this trial is testing

Noninvasive vs. Invasive Lung Evaluation

Who this might be right for
Non-Small Cell Lung Cancer
Guardant Health, Inc. 306
Early research (Phase 1)Study completedNCT04626843
What this trial is testing

Intermittent Fasting and CLL/SLL

Who this might be right for
NeoplasmsLeukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic+3 more
Eleah Stringer 15
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00988858
What this trial is testing

Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 55
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Early research (Phase 1)Study completedNCT00533585
What this trial is testing

BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 23
Not applicableUnknownNCT01998425
What this trial is testing

Circulating Fibrocytes in Non-small Cell Lung Cancer.

Who this might be right for
NSCLC
Chang Gung Memorial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT05553808
What this trial is testing

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Who this might be right for
Neoplasms
GlaxoSmithKline 105
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552
What this trial is testing

Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Testing effectiveness (Phase 2)Study completedNCT00212043
What this trial is testing

Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma

Who this might be right for
Non Small Cell Lung Cancer
National University Hospital, Singapore 74
Next Page